Evidence map›Paper›PMID 37522715›Full record

ArticleBlood advances2023

ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice.

Mackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, Ruopeng Feng, Ilaria Iacobucci, Pradyumna Baviskar, Xujie Zhao, Alexa N Stroh, Chunliang Li, Patrick Ozark and 10 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. A germlineScience advances · 2025
    Article
  10. A novel truncated fusion geneFrontiers in oncology · 2025
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Mackenzie BloomSt. Jude Graduate School of Biomedical Sciences, Memphis, TN.ORCID 0000-0002-1779-7680
Ninad OakDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-9806-0217
Rebekah Baskin-DoerflerFlow Cytometry & Cell Sorting Resource, St. Jude Children's Research Hospital, Memphis, TN.
Ruopeng FengDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Ilaria IacobucciDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Pradyumna BaviskarDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Xujie ZhaoDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
Alexa N StrohDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Chunliang LiDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-5938-5510
Patrick OzarkDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-4047-5102
Heather S TillmanDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-9623-2812
Yichao LiDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-5791-096X
Katherine C VerbistDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN.
Sabrin AlbeituniDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Danny C ScottDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-7688-5568
Moeko T KingDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN.
Shannon L McKinney-FreemanDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Mitchell J WeissDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Jun J YangDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-5581-6555
St. Jude Children's Research Hospital · US

Funding

Pathogenesis of ETV6-Related Acute Lymphoblastic LeukemiaR01CA241452 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI NICHOLS, KIM ERIKA · 2020 to 2025
$2.6M
Role of the ETV6 transcription factor in hematopoietic stem cell functionF31HL154645 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC · PI BLOOM, MACKENZIE · 2020 to 2022
$75k
NCI NIH HHS R01 CA241452NHLBI NIH HHS F31 HL154645
6 · The paper itself

Abstract

ETS variant 6 (ETV6) encodes a transcriptional repressor expressed in hematopoietic stem and progenitor cells (HSPCs), where it is required for adult hematopoiesis. Heterozygous pathogenic germline ETV6 variants are associated with thrombocytopenia 5 (T5), a poorly understood genetic condition resulting in thrombocytopenia and predisposition to hematologic malignancies. To elucidate how germline ETV6 variants affect HSPCs and contribute to disease, we generated a mouse model harboring an Etv6R355X loss-of-function variant, equivalent to the T5-associated variant ETV6R359X. Under homeostatic conditions, all HSPC subpopulations are present in the bone marrow (BM) of Etv6R355X/+ mice; however, these animals display shifts in the proportions and/or numbers of progenitor subtypes. To examine whether the Etv6R355X/+ mutation affects HSPC function, we performed serial competitive transplantation and observed that Etv6R355X/+ lineage-sca1+cKit+ (LSK) cells exhibit impaired reconstitution, with near complete failure to repopulate irradiated recipients by the tertiary transplant. Mechanistic studies incorporating cleavage under target and release under nuclease assay, assay for transposase accessible chromatin sequencing, and high-throughput chromosome conformation capture identify ETV6 binding at inflammatory gene loci, including multiple genes within the tumor necrosis factor (TNF) signaling pathway in ETV6-sufficient mouse and human HSPCs. Furthermore, single-cell RNA sequencing of BM cells isolated after transplantation reveals upregulation of inflammatory genes in Etv6R355X/+ progenitors when compared to Etv6+/+ counterparts. Corroborating these findings, Etv6R355X/+ HSPCs produce significantly more TNF than Etv6+/+ cells post-transplantation. We conclude that ETV6 is required to repress inflammatory gene expression in HSPCs under conditions of hematopoietic stress, and this mechanism may be critical to sustain HSPC function.

Indexed as

Hematopoietic Stem CellsThrombocytopeniaAnimalsBone MarrowBone Marrow CellsETS Translocation Variant 6 ProteinHematopoiesisHumansMiceETS Translocation Variant 6 Protein

Identifiers

PMID37522715
PMCPMC10514086
OpenAlexW4385407141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.